| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2357 |
Injection, omalizumab, 5 mg |
349 |
255 |
$697K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,408 |
2,303 |
$669K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,441 |
7,166 |
$361K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,044 |
378 |
$296K |
| 96401 |
|
1,495 |
1,108 |
$129K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
986 |
967 |
$79K |
| 95117 |
|
7,671 |
3,852 |
$66K |
| 94010 |
|
2,327 |
2,214 |
$53K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
294 |
290 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,844 |
1,671 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
713 |
697 |
$24K |
| 99000 |
|
1,998 |
1,596 |
$18K |
| 94060 |
|
449 |
439 |
$16K |
| 95115 |
|
1,658 |
899 |
$12K |
| 0071A |
|
270 |
270 |
$10K |
| 94375 |
|
329 |
322 |
$10K |
| 99215 |
Prolong outpt/office vis |
123 |
118 |
$9K |
| 0072A |
|
182 |
182 |
$7K |
| 99358 |
Prolong nursin fac eval 15m |
127 |
126 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
427 |
392 |
$6K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
2,503 |
2,411 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
111 |
98 |
$4K |
| 0001A |
|
122 |
120 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
57 |
$4K |
| 0002A |
|
78 |
78 |
$3K |
| 86328 |
|
107 |
95 |
$3K |
| 87428 |
|
37 |
35 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
55 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
154 |
111 |
$2K |
| 95012 |
|
97 |
97 |
$2K |
| 98960 |
|
216 |
215 |
$1K |
| 94728 |
|
13 |
12 |
$427.40 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
373 |
365 |
$333.69 |
| 0004A |
|
16 |
15 |
$280.00 |
| 94760 |
|
3,272 |
3,010 |
$143.32 |
| 96160 |
|
1,807 |
1,715 |
$139.72 |
| A4617 |
Mouth piece |
85 |
85 |
$126.75 |
| 94761 |
|
561 |
457 |
$89.98 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
16 |
$70.87 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
395 |
385 |
$22.66 |
| 94664 |
|
444 |
433 |
$0.00 |
| 99072 |
|
34 |
34 |
$0.00 |
| J3590 |
Unclassified biologics |
282 |
228 |
$0.00 |